Antibody and Safety Study of 6 Doses of NicVAX in Smokers

NCT00598325 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nabi Biopharmaceuticals